BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999;116:193-207. [PMID: 9869618 DOI: 10.1016/s0016-5085(99)70244-1] [Cited by in Crossref: 182] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Anderson GJ, Powell LW. HFE and non-HFE hemochromatosis. Int J Hematol 2002;76:203-7. [PMID: 12416729 DOI: 10.1007/BF02982788] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wallace DF, Subramaniam VN. The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data. Genet Med. 2016;18:618-626. [PMID: 26633544 DOI: 10.1038/gim.2015.140] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
3 Samarasena J, Winsor W, Lush R, Duggan P, Xie Y, Borgaonkar M. Individuals homozygous for the H63D mutation have significantly elevated iron indexes. Dig Dis Sci 2006;51:803-7. [PMID: 16615007 DOI: 10.1007/s10620-006-3210-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
4 Lee SM, Loguinov A, Fleming RE, Vulpe CD. Effects of strain and age on hepatic gene expression profiles in murine models of HFE-associated hereditary hemochromatosis. Genes Nutr 2015;10:443. [PMID: 25427953 DOI: 10.1007/s12263-014-0443-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-58. [PMID: 10739755 DOI: 10.1086/302862] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 5.8] [Reference Citation Analysis]
6 Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, Bacon BR, Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA. 2000;97:2214-2219. [PMID: 10681454 DOI: 10.1073/pnas.040548097] [Cited by in Crossref: 190] [Cited by in F6Publishing: 178] [Article Influence: 9.0] [Reference Citation Analysis]
7 Kong X, Xie L, Zhu H, Song L, Xing X, Yang W, Chen X. Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review. Orphanet J Rare Dis 2019;14:171. [PMID: 31286966 DOI: 10.1186/s13023-019-1097-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 2001;98:2707-2711. [PMID: 11226304 DOI: 10.1073/pnas.051630898] [Cited by in Crossref: 136] [Cited by in F6Publishing: 125] [Article Influence: 6.8] [Reference Citation Analysis]
9 Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut. 2002;50:248-252. [PMID: 11788568 DOI: 10.1136/gut.50.2.248] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 4.5] [Reference Citation Analysis]
10 Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci. 2002;47:419-426. [PMID: 11855561 DOI: 10.1023/a:1013746828074] [Cited by in Crossref: 60] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
11 Akesson A, Stål P, Vahter M. Phlebotomy increases cadmium uptake in hemochromatosis. Environ Health Perspect 2000;108:289-91. [PMID: 10753085 DOI: 10.1289/ehp.108-1638026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
12 Sebastiani G, Wallace DF, Davies SE, Kulhalli V, Walker AP, Dooley JS. Fatty liver in H63D homozygotes with hyperferritinemia. World J Gastroenterol 2006;12:1788-92. [PMID: 16586555 DOI: 10.3748/wjg.v12.i11.1788] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kim J, Buckett PD, Wessling-Resnick M. Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS One 2013;8:e64944. [PMID: 23705020 DOI: 10.1371/journal.pone.0064944] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
14 Quatredeniers M, Mendes-Ferreira P, Santos-Ribeiro D, Nakhleh MK, Ghigna MR, Cohen-Kaminsky S, Perros F. Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms. Cells 2021;10:477. [PMID: 33672218 DOI: 10.3390/cells10020477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Thomson AB, Keelan M, Thiesen A, Clandinin MT, Ropeleski M, Wild GE. Small bowel review: normal physiology part 1. Dig Dis Sci 2001;46:2567-87. [PMID: 11768247 DOI: 10.1023/a:1012794505897] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
16 Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46:2050-68. [PMID: 11106350 [PMID: 11106350 DOI: 10.1093/clinchem/46.12.2050] [Cited by in Crossref: 213] [Cited by in F6Publishing: 87] [Article Influence: 10.7] [Reference Citation Analysis]
17 Nairz M, Weiss G. Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis. Wien Klin Wochenschr. 2006;118:442-462. [PMID: 16957974 DOI: 10.1007/s00508-006-0653-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
18 Sproule TJ, Jazwinska EC, Britton RS, Bacon BR, Fleming RE, Sly WS, Roopenian DC. Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci U S A 2001;98:5170-4. [PMID: 11309500 DOI: 10.1073/pnas.091088998] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
19 Alizadeh BZ, Njajou OT, Hazes JM, Hofman A, Slagboom PE, Pols HA, van Duijn CM. The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann Rheum Dis 2007;66:1436-42. [PMID: 17284543 DOI: 10.1136/ard.2006.063099] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
20 Attarwala H, Han M, Kim J, Amiji M. Oral nucleic acid therapy using multicompartmental delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10. [PMID: 28544521 DOI: 10.1002/wnan.1478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Uhl P, Fricker G, Haberkorn U, Mier W. Current status in the therapy of liver diseases. Int J Mol Sci. 2014;15:7500-7512. [PMID: 24786290 DOI: 10.3390/ijms15057500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
22 Allen MK. Hereditary hemochromatosis: a literature review and case report. Physiother Can 2010;62:276-84. [PMID: 21629607 DOI: 10.3138/physio.62.3.276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Sebastiani G, Walker AP. HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol 2007;13:4673-89. [PMID: 17729389 DOI: 10.3748/wjg.v13.i35.4673] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
24 Fan Y, Dhaliwal HK, Menon AV, Chang J, Choi JE, Amiji MM, Kim J. Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system. Nanomedicine 2019;22:102091. [PMID: 31626992 DOI: 10.1016/j.nano.2019.102091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bittencourt PL, Marin ML, Couto CA, Cançado EL, Carrilho FJ, Goldberg AC. Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis. Clinics (Sao Paulo) 2009;64:837-41. [PMID: 19759876 DOI: 10.1590/S1807-59322009000900003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Tavill AS, Adams PC. A diagnostic approach to hemochromatosis. Can J Gastroenterol 2006;20:535-40. [PMID: 16955151 DOI: 10.1155/2006/934098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Trinder D, Fox C, Vautier G, Olynyk JK. Molecular pathogenesis of iron overload. Gut 2002;51:290-5. [PMID: 12117898 DOI: 10.1136/gut.51.2.290] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
28 Vieira FM, Nakhle MC, Abrantes-Lemos CP, Cançado EL, Reis VM. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients. An Bras Dermatol 2013;88:530-40. [PMID: 24068123 DOI: 10.1590/abd1806-4841.20132048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
29 Fleming RE, Sly WS. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J Clin Invest 2001;108:521-2. [PMID: 11518724 DOI: 10.1172/JCI13739] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
30 Adams PC, Jeffrey G, Alanen K, Chakrabarti S, Preshaw R, Howson W, Grant D. Transplantation of haemochromatosis liver and intestine into a normal recipient. Gut 1999;45:783. [PMID: 10517921 DOI: 10.1136/gut.45.5.783] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
31 Adams PC. Population screening for haemochromatosis. Gut 2000;46:301-3. [PMID: 10673284 DOI: 10.1136/gut.46.3.301] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]